Nikhil Patel medical student 1 , Dipak Ram grid trainee in paediatric neurology 2 , Nina Swiderska grid trainee in paediatric neurology 2 , Leena D Mewasingh consultant paediatric neurologist 3 , Richard W Newton consultant paediatric neurologist 1 , Martin Offringa professor, senior scientist and programme head 4

No abstract

Service Email Alerting click here. top right corner of the article or Receive free email alerts when new articles cite this article-sign up in the box at the http://genome.cshlp.org/subscriptions

Periodic laboratory monitoring is important in detecting hepatotoxicity at an early stage, thereby preventing mortality. Sequential reintroduction is often successful.

Intravascular lead extraction is a safe and efficient method of removing leads. However, there is a subgroup of patients with systemic sepsis with raised inflammatory markers who are at high risk of in-hospital mortality. Long-term follow-up demonstrates mortality which is a marker of the underlying etiology for device implantation, with heart failure patients particularly at risk.